Table 2.
Univariate analyses of associated clinicopathological characteristics with progression free survival and overall survival
| Variables | Categories | P value of PFS | P value of OS |
|---|---|---|---|
| Age(years) | ≤55 | 0.968 | 0.653 |
| >55 | |||
| FIGO Stage | III | 0.583 | 0.454 |
| IV | |||
| Histology | High-grade serous | 0.310 | 0.314 |
| Others | |||
| Cytoreduction to no visible disease | Yes | 0.033* | 0.039* |
| No | |||
| Chemotherapy cycles >8 | Yes | 0.286 | 0.148 |
| No |
* Statistically significant (P < 0.05); FIGO: federation of gynecology and obstetrics; PFS: progression free survival; OS: overall survival